StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$2.02−0.02 (-0.98%)

Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –

Compugen price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Compugen's price to book ratio was 2.2× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.6× to 3.6×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−0.6
2025Dec 31, 20252.8×+0.5
2024Dec 31, 20242.3×−0.5
2023Dec 29, 20232.8×+2.1
2022Dec 30, 20220.7×−2.8
2021Dec 31, 20213.5×−4.2
2020Dec 31, 20207.7×−3.9
2019Dec 31, 201911.6×+8.6
2018Dec 31, 20183.1×+0.4
2017Dec 29, 20172.7×−0.7
2016Dec 30, 20163.4×−0.0
2015Dec 31, 20153.4×−0.7
2014Dec 31, 20144.1×−12.5
2013Dec 31, 201316.6×+8.5
2012Dec 31, 20128.1×+2.2
2011Dec 30, 20115.9×+0.0
2010Dec 31, 20105.9×–

More Compugen figures

See a number that looks wrong?